HERTFORDSHIRE, England, and PITTSBURGH, May 18, 2019 /PRNewswire/ -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced four scientific abstracts from the Wixela™ Inhub™ ...

If Mylan’s aggressive pricing for its generic Advair product sounds familiar, that’s because it is. The knockoffs giant set the list price for Wixela Inhub, its copy of GlaxoSmithKline’s respiratory ...

wixela-product-image Wixela Inhub (fluticasone propionate and salmeterol inhalation powder), the first substitutable generic of Advair Diskus (GlaxoSmithKline), has been made available by Mylan Mylan ...

Mylan N.V. MYL received a significant boost when the FDA approved its generic version of GlaxoSmithKline's GSK Advair Diskus - Wixela Inhub - following a few setbacks. Notably, this is the first ...

1. Wixela Inhub is Mylan’s generic version of Advair, an asthma treatment made by GlaxoSmithKline. 2. Tosymra is a sumatriptan nasal spray used to treat migraines in adults. 3. Imbruvica in ...

After the FDA shot down Mylan’s generic Advair for the second time in June, executives said they addressed the “minor deficiencies” and an approval should follow in mid-October. A week into November, ...

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...

FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The first generic version of the popular Advair asthma inhaler has been approved by U.S.

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration today approved Mylan’s version in three strengths for ages 4 and ...